SK Pharmteco Expands with Controlling Stake in Center for Breakthrough Medicines

CBM brings extensive cell and gene therapy expertise to SK pharmteco portfolio and continues SK pharmteco’s strategy to deliver end-to-end, multi-mod...

September 21, 2023 | Thursday | News
Kineta Announces New Research Agreement to Evaluate VISTA Biomarker Expression

The primary objective is to evaluate VISTA as a biomarker to guide patient selection and treatment optimization for VISTA-targeted therapies where no stand...

September 19, 2023 | Tuesday | News
NTT and NCNP to Collaborate in Japan to Develop Brain Bio-Digital Twin Technology

News Highlights: Brain Bio-Digital Twin technology has the potential to change medical treatment practices by eliminating the need for invasive and cost...

September 15, 2023 | Friday | News
Mayo Clinic and GE HealthCare Enter Strategic Collaboration to Advance Innovation in Medical Imaging and Theranostics

Mayo Clinic and GE HealthCare announce a strategic healthcare collaboration for research and product development programs aimed to transform the experience...

September 15, 2023 | Friday | News
Bristol Myers Squibb's LPA1 Antagonist Slows Lung Decline in Pulmonary Fibrosis Study

Results show 26 weeks of treatment with twice-daily 60 mg dose of BMS-986278 resulted in a 69% relative reduction in the rate of decline in percent predict...

September 11, 2023 | Monday | News
Revvity Launches Next-Gen Imaging Tools to Drive Research Breakthroughs

IVIS® Spectrum 2 and IVIS SpectrumCT 2imaging systems — new flagship platforms setting the standard in high-throughput performance and versat...

September 06, 2023 | Wednesday | News
Neurophet becomes the inaugural Korean firm selected by Roche Diagnostics for the Startup Creasphere APAC Program

Neurophet, an artificial intelligence (AI) solution company for brain disease, announced its participation in the global startup innovation program 'Startu...

September 06, 2023 | Wednesday | News
MedAlliance Enrolls First Patient in SELUTION SLR LOVE-DEB Coronary Study

The aim of the LOVE-DEB Study (Large de-NOVo coronary artEry disease treated with sirolimus Drug Eluting Balloon: prospective evaluation of safety & ef...

September 06, 2023 | Wednesday | News
Stallergenes Greer & Nestlé Partner for Palforzia® Peanut Allergy Treatment

Peanut allergy currently affects approximately 2% of the general population of Western nations1, and the prevalence of peanut allergy doubled among childre...

September 05, 2023 | Tuesday | News
Sabin Institute Launches Global HPV Consortium in Malaysia to Prevent Cervical Cancer

“We are building a new ecosystem in global public health,” said Anuradha Gupta, President of Global Immunization at Sabin. “We aim to cre...

September 05, 2023 | Tuesday | News
Rapid Medical™ Gains Approval in China for the World’s Only Adjustable Thrombectomy Device

Rapid Medical™, a leading developer of advanced neurovascular devices, announced Chinese approval for its TIGERTRIEVER revascularization device. With...

September 01, 2023 | Friday | News
Asieris Receives NMPA IND Approval for APL-1401 in Ulcerative Colitis

The study is a randomized, double-blind Phase Ib study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of APL-1401 in patie...

August 30, 2023 | Wednesday | News
Johnson & Johnson Vision Launches ELITA™ Platform for Myopia Correction with SILK Procedure

Next-generation laser vision correction provides next-day results and recovery1,2 The next-generation ELITATM Fe...

August 30, 2023 | Wednesday | News
GE Introduces Vscan Air SL: Handheld Wireless Ultrasound for Quick Cardiac Assessments

With a dual-headed probe, the Vscan Air SL offers a sector array and a linear array on a single device which is ideal for switching between focused cardi...

August 28, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in